TEMARIL Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Temaril, and when can generic versions of Temaril launch?
Temaril is a drug marketed by Allergan Herbert and is included in one NDA.
The generic ingredient in TEMARIL is trimeprazine tartrate. There are five drug master file entries for this compound. Additional details are available on the trimeprazine tartrate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for TEMARIL?
- What are the global sales for TEMARIL?
- What is Average Wholesale Price for TEMARIL?
Summary for TEMARIL
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 37 |
| DailyMed Link: | TEMARIL at DailyMed |
US Patents and Regulatory Information for TEMARIL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Allergan Herbert | TEMARIL | trimeprazine tartrate | CAPSULE, EXTENDED RELEASE;ORAL | 011316-004 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
| Allergan Herbert | TEMARIL | trimeprazine tartrate | SYRUP;ORAL | 011316-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
| Allergan Herbert | TEMARIL | trimeprazine tartrate | TABLET;ORAL | 011316-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
